USD 11.99 Billion
Intravenous Solutions Market Size, Share, Growth Analysis, By Product (Total Parenteral Nutrition and Peripheral Parenteral Nutrition), By Nutrients (Carbohydrates, Parenteral Lipid Emulsion), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35E2051 |
Region:
Global |
Published Date: November, 2024
Pages:
192
|Tables:
63
|Figures:
70
Intravenous Solutions Market Insights
Global Intravenous Solutions Market size was valued at USD 11.99 Billion in 2022 and is poised to grow from USD 12.95 Billion in 2023 to USD 23.96 Billion by 2031, growing at a CAGR of 8.0% in the forecast period (2024-2031).
As the name suggests, intravenous solutions are sterile liquids that are administered into the patient’s bloodstream directly via vein. They hold multiple medical purposes like hydration, nutritional support, delivery of medicines, and electrolytes. The global intravenous solutions market is significantly fueled by the rising cases of chronic illnesses, mounting demand for home healthcare, and the ever-growing elderly population. Furthermore, improvements in technologies like infusion devices and an inclination towards sustainable manufacturing and packaging are impacting the market growth. However, the market is negatively affected by factors like strict regulatory needs, significant manufacturing costs, and rising competition among emerging and established players. Yet, the market is facing opportunities from the growing focus on nutritional solutions and surging demand for personalized medicine.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Carbohydrates
Fastest Growth
Vitamins & Minerals
Growth Rate
8.0%
Global Intravenous Solutions Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Intravenous Solutions Market Segmental Analysis
Global Intravenous Solutions Market is segmented by Product, Nutrients, and region. Based on Product, the market is segmented into Total Parenteral Nutrition, Peripheral Parenteral Nutrition. Based on Nutrients, the market is segmented into Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids, Parenteral Lipid Emulsion, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Product
Based on product, the intravenous solutions market is segmented as total parenteral nutrition and peripheral parenteral nutrition. The total parenteral nutrition segment held a notable market share in 2023 and is anticipated to lead over the estimated period owing to the increasing prevalence of chronic diseases on the global scale. The rising rates of chronic conditions and illnesses that harm digestion like diverse gastrointestinal conditions and cancer are propelling the demand for total parenteral nutrition. The growing elderly population also needs better nutritional support via TPN since this population may encounter issues with oral intake. These factors are fueling the segment’s growth.
The peripheral parenteral nutrition segment is anticipated to be the fastest-growing segment owing to its short-term nutritional aid that is suitable for certain patients. Short-term nutrition is recommended for patients facing mild malnutrition or recovering from recent surgery. Also, peripheral parenteral nutrition is minimally invasive since it is administrated via veins and is increasingly preferred by healthcare experts and patients. Moreover, growing number of patients suffering from gastrointestinal problems or individuals who cannot intake foods orally are advised PPN, thus driving the segment’s growth.
Analysis by Nutrients
Based on nutrients, the market is segmented into carbohydrates, vitamins and minerals, single dose amino acids, parenteral lipid emulsion, and others. The single dose amino acids segment dominated the market in the past years and is projected to lead in future as well owing to its essential nutrient support and safety and convenience. Amino acids are vital for tissue repair, protein synthesis, and overall metabolic functions, increasing their significance for patients who cannot consume easily. Also, prepacked single dose acids decrease contamination risk and streamline administration, increasing their prominence among healthcare professionals. These factors are notably impacting the growth of the segment.
On the other hand, the vitamins and minerals segment is projected to hold a notable market share in the coming years owing to its support for malnourished individuals and better customizations. The rising cases of malnutrition and associated conditions that damage nutrient absorption fuel the demand for IV minerals and vitamins, especially in hospitals. IV formulations also enable customized mineral and vitamin administration to individuals depending on patient needs, improving the effectiveness of treatment.
Global Intravenous Solutions Market Size By Product
To get detailed analysis on other segments, Request For Free Sample Report
Intravenous Solutions Market Regional Insights
Region-wise, North America is the dominating region among others and is expected to lead over the forecast period owing to the region being an innovation center and early adopter of improved infusion technologies. North America is a leading region for several biotechnology and pharmaceutical companies that are heavily investing in research and development of improved IV technologies and solutions. Moreover, the deployment of advanced infusion solutions like smart monitoring systems and pumps improve efficacy and safety of IV therapies. This increases their prominence and importance among healthcare professionals. Regional growth is also impacted by the rising patient population of chronic illness, including cancer, diabetes, cardiovascular diseases, and more, resulting in increased demand of IV therapies. The leading players in the region include Baxter International Inc., B. Braun Medical Inc., McKesson Corporation, Cardinal Health, Inc., Amgen Inc., and more.
Asia-Pacific is the fastest-growing region in the global intravenous solutions market due to the growing healthcare investment and improving healthcare facilities. Speedy economic growth in nations like India, China, and Japan is increasing investments and spending in healthcare infrastructure. Moreover, notable investments are also seen to enhance the accessibility and quality of healthcare services, streamlining the deployment of IV therapies in clinics and hospitals. Furthermore, the region is witnessing adoption and development of improved infusion technologies like automated systems and smart pumps that improve treatment efficiency and patient safety.
Global Intravenous Solutions Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Intravenous Solutions Market Dynamics
Drivers
Notable Expansion of Home Healthcare
- More patients prefer treatments at home, especially for chronic illnesses, resulting in mounting demand for home IV and infusion therapies. This is significantly fueling the demand for home healthcare. It offers optimal patient comfort and aids compliance, which encourages healthcare professionals to offer more UV solutions for home purposes.
Growing Acceptance and Awareness of IV Therapies
- Currently, efforts are being taken to educate patients and a large population about the benefits of IV therapies. Hence, increasing awareness among healthcare providers and patients is contributing to increasing acceptance and the adoption of therapies. Also, the inclination towards exhaustive treatment strategies that comprise IV technologies for patient care is gaining prominence.
Restraints
Safety Concerns and Risk of Contamination
- The possibilities of contamination during administration or production of IV technologies may pose major safety issues. This may result in increased and time consuming regulatory and scrutiny challenges. Thus, impeding its adoption and the market growth. Moreover, patients may witness side-effects to certain IV therapies, which may create hesitation among medical professionals from using these products.
Supply Chain Vulnerabilities
- The supply chain for IV technologies may be prone to disturbances because of geopolitical tensions, natural disasters, pandemics, affecting delivery and availability. This could hinder the adoption of these therapies and hamper market growth. Also, variations in raw material prices and availability may impact production pricing and stability.
Request Free Customization of this report to help us to meet your business objectives.
Intravenous Solutions Market Competitive Landscape
The Global Intravenous Solutions Market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment.
Top Player’s Company Profiles
- Akshar Pharma
- Fresenius Kabi AG
- MEDEVAC LIFESCIENCES PVT LTD
- Pfizer, Inc.
- LXIR MEDILABS PVT. LTD
- Otsuka Pharmaceutical Co., Ltd.
- Baxter
- B. Braun
- Melsungen AG
- Aishwarya Healthcare
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Health Care
- ICU Medical, Inc.
- Grifols S.A.
- AptarGroup, Inc.
- Sagent Pharmaceuticals, Inc.
- Amgen Inc.
- Novartis AG
Recent Developments
- In April 2024, Baxter International Inc. pronounced the expansion of its pharmaceuticals product line by launching five injectables in the United States. These introductions reflect Baxter’s commitment to different products that resolve patient needs in major areas like anti-hypotensive and anti-infective medications.
- In May 2022, Fresenius Kabi completed the acquisition of Ivenix Incorporation, an expert infusion therapy company. The company expanding in MedTech, will offer more advanced infusion therapy offerings. This acquisition is beneficial for capabilities and market offerings as Fresenius Kabi welcomes a unique and committed technology and healthcare team to its family.
- In March 2022, Otsuka Pharmaceutical Co., Ltd. declared that it received approval for its SAMTASU® 8mg and 16mg Intravenous Infusion for the development and supply. The prodrug, SAMTASU, is used for treating cardiac edema.
Intravenous Solutions Key Market Trends
- Rise of Home Infusion Therapy: Currently, individuals with chronic diseases are being treated at home due to several benefits like improvements in portable infusion therapies. This trend notably improves patient experience by offering them optimal comfort and reducing hospital admissions. Home infusion treatments are mostly supported by telehealth facilities that enable medical providers to remotely monitor patients, saving time.
- Smart IV Technologies and Solutions: The improvement of smart infusion pumps that can control flow rate and dosages in real-time is gaining traction. These devices are embedded with EHR for enhanced monitoring. Moreover, several companies are focusing on mobile applications that help better management of fusion therapy, enabling provider and patients to smoothly track patient status and medicine administration.
Intravenous Solutions Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the intravenous solutions market is witnessing considerable growth due to the surging cases of chronic diseases, supportive regulatory frameworks, and increasing number of innovations and investments for research and development. The market is also propelled by the increased emphasis on patient safety. However, the market is restrained by significant manufacturing costs and changing healthcare policies. North America is anticipated to lead the market owing to the growing acceptance and awareness of the advantages of IV therapies, focus on patient safety, and emphasis on home healthcare. Nonetheless, some opportunities for the growth of the market include increasing sustainability initiatives, growing health awareness, and investments in improved quality management systems.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 11.99 Billion |
| Market size value in 2031 | USD 23.96 Billion |
| Growth Rate | 8.0% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Intravenous Solutions Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Intravenous Solutions Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Intravenous Solutions Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Intravenous Solutions Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Intravenous Solutions Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Intravenous Solutions Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
